SCHEMBL18565371

SCHEMBL18565371

Cn1c2ccccc2c2cccc(-c3ccc4c(c3)oc3ccccc34)c21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALKBH5 Q6P6C2 1/20 0.45
FTO Q9C0B1 1/20 0.45
HSP90AA1 P07900 1/20 0.41
IDO1 P14902 1/20 0.41
ALOX5 P09917 1/20 0.41
PRKDC P78527 1/20 0.40
AHR P35869 2/20 0.40
GPR3 P46089 1/20 0.40
MAPT P10636 3/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.36
KIF11 P52732 1/20 0.35
HSD17B10 Q99714 1/20 0.35
RXRA P19793 1/20 0.35
RXRB P28702 1/20 0.35
HCRTR1 O43613 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18565397 0.87 ALOX5 (0.38) ALKBH5FTOHSP90AA1ALOX5PRKDC
SCHEMBL18565482 0.85 ALOX5 (0.38) ALKBH5FTOHSP90AA1IDO1ALOX5
SCHEMBL18565464 0.84 PRKDC (0.41) HSP90AA1ALOX5PRKDCAHRMAPT
SCHEMBL18565385 0.84 ALOX5 (0.41) HSP90AA1ALOX5PRKDCAHRGPR3
SCHEMBL18565437 0.83 SIRT2 (0.37) ALOX5PRKDCAHRMAPTMEN1
SCHEMBL16376468 0.83 ALKBH5 (0.53) ALKBH5FTOHSP90AA1IDO1GPR3
SCHEMBL20706809 0.82 KDM4E (0.42) ALOX5PRKDCAHRMAPTMEN1
SCHEMBL18565369 0.81 RXRA (0.51) AHRGPR3MAPTMEN1KMT2A
SCHEMBL20987534 0.80 ALOX5 (0.47) ALKBH5FTOHSP90AA1IDO1ALOX5
SCHEMBL18565377 0.80 GPR3 (0.48) AHRGPR3MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-05-14 US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device EED, BMI1, CD99 ALKBH5 265/4885FTO 202/4885HSP90AA1 4595/4885
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE EED, BMI1, CD99 ALKBH5 265/4885FTO 202/4885HSP90AA1 4595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.